Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Surfactants in glyphosate products in Japan.

Kamata H, Nakano S, Shima N, Fujita Y, Usui K, Kamijo Y, Hanazawa T, Katagi M.

Clin Toxicol (Phila). 2019 Aug 7:1-2. doi: 10.1080/15563650.2019.1648818. [Epub ahead of print] No abstract available.

PMID:
31389728
2.

Advanced Technology for Gene Delivery with Homing Peptides to Spinal Cord through Systemic Circulation in Mice.

Terashima T, Ogawa N, Sato T, Katagi M, Nakae Y, Okano J, Maegawa H, Kojima H.

Mol Ther Methods Clin Dev. 2019 May 10;13:474-483. doi: 10.1016/j.omtm.2019.04.008. eCollection 2019 Jun 14.

3.

Incorporation of zolpidem and methoxyphenamine into white hair strands after single administrations: Influence of hair pigmentation on drug incorporation.

Shima N, Nitta A, Kamata T, Sasaki K, Matsuta S, Ishikawa A, Asai R, Wada M, Kakehashi H, Nakano S, Kamata H, Sato T, Tsuchihashi H, Miki A, Katagi M.

Forensic Sci Int. 2019 Aug;301:67-75. doi: 10.1016/j.forsciint.2019.05.013. Epub 2019 May 11.

PMID:
31129374
4.

[Hair Testing for Drugs in the Field of Forensics].

Shima N, Sasaki K, Kamata T, Miki A, Katagi M.

Yakugaku Zasshi. 2019;139(5):705-713. doi: 10.1248/yakushi.18-00166-4. Review. Japanese.

5.

Epidemiological study of indirect blood pressure measured using oscillometry in clinically healthy cats at initial evaluation.

Hori Y, Heishima Y, Yamashita Y, Iguchi M, Nakamura K, Isayama N, Onodera H, Kitade A, Kanno N, Hirakawa A, Katagi M, Ibaragi T, Yamano S, Aramaki Y, Sawada T.

J Vet Med Sci. 2019 Apr 16;81(4):513-516. doi: 10.1292/jvms.18-0187. Epub 2019 Feb 12.

6.

A role for bone marrow-derived cells in diabetic nephropathy.

Nobuta H, Katagi M, Kume S, Terashima T, Araki SI, Maegawa H, Kojima H, Nakagawa T.

FASEB J. 2019 Mar;33(3):4067-4076. doi: 10.1096/fj.201801825R. Epub 2018 Nov 29.

PMID:
30496699
7.

Stem cell factor induces polarization of microglia to the neuroprotective phenotype in vitro.

Terashima T, Nakae Y, Katagi M, Okano J, Suzuki Y, Kojima H.

Heliyon. 2018 Oct 1;4(10):e00837. doi: 10.1016/j.heliyon.2018.e00837. eCollection 2018 Oct.

8.

Metabolism of α-PHP and α-PHPP in humans and the effects of alkyl chain lengths on the metabolism of α-pyrrolidinophenone-type designer drugs.

Matsuta S, Shima N, Kakehashi H, Kamata H, Nakano S, Sasaki K, Kamata T, Nishioka H, Miki A, Zaitsu K, Tsuchihashi H, Katagi M.

Forensic Toxicol. 2018;36(2):486-497. doi: 10.1007/s11419-018-0428-7. Epub 2018 May 28.

9.

Gene Therapy for Neuropathic Pain through siRNA-IRF5 Gene Delivery with Homing Peptides to Microglia.

Terashima T, Ogawa N, Nakae Y, Sato T, Katagi M, Okano J, Maegawa H, Kojima H.

Mol Ther Nucleic Acids. 2018 Jun 1;11:203-215. doi: 10.1016/j.omtn.2018.02.007. Epub 2018 Feb 27.

10.

Diagnostic accuracy of plasma atrial natriuretic peptide concentrations in cats with and without cardiomyopathies.

Heishima Y, Hori Y, Nakamura K, Yamashita Y, Isayama N, Kanno N, Katagi M, Onodera H, Yamano S, Aramaki Y.

J Vet Cardiol. 2018 Aug;20(4):234-243. doi: 10.1016/j.jvc.2018.04.008. Epub 2018 May 25.

PMID:
29807749
11.

Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy.

Hori Y, Iguchi M, Heishima Y, Yamashita Y, Nakamura K, Hirakawa A, Kitade A, Ibaragi T, Katagi M, Sawada T, Yuki M, Kanno N, Inaba H, Isayama N, Onodera H, Iwasa N, Kino M, Narukawa M, Uchida S.

J Vet Intern Med. 2018 May;32(3):922-929. doi: 10.1111/jvim.15131. Epub 2018 Apr 16.

12.

Relationship between indirect blood pressure and various stages of chronic kidney disease in cats.

Hori Y, Heishima Y, Yamashita Y, Isayama N, Kanno N, Nakamura K, Iguchi M, Ibaragi T, Onodera H, Aramaki Y, Hirakawa A, Yamano S, Katagi M, Kitade A, Sawada T.

J Vet Med Sci. 2018 Mar 24;80(3):447-452. doi: 10.1292/jvms.17-0620. Epub 2018 Jan 3.

13.

Detection of butane gas inhalation at 16days after hypoxic encephalopathy: A case report.

Sato T, Nishioka H, Tsuboi K, Katagi M, Miki A, Saito T, Abe S, Nomura M, Kitagawa M, Tsuchihashi H, Suzuki K.

Leg Med (Tokyo). 2017 Nov;29:34-37. doi: 10.1016/j.legalmed.2017.09.005. Epub 2017 Oct 3.

PMID:
29017087
14.

Incorporation of Zolpidem into Hair and Its Distribution after a Single Administration.

Shima N, Sasaki K, Kamata T, Matsuta S, Wada M, Kakehashi H, Nakano S, Kamata H, Nishioka H, Sato T, Tsuchihashi H, Miki A, Katagi M.

Drug Metab Dispos. 2017 Mar;45(3):286-293. doi: 10.1124/dmd.116.074211. Epub 2016 Dec 14.

PMID:
27974380
15.

Hyperglycemia Induces Skin Barrier Dysfunctions with Impairment of Epidermal Integrity in Non-Wounded Skin of Type 1 Diabetic Mice.

Okano J, Kojima H, Katagi M, Nakagawa T, Nakae Y, Terashima T, Kurakane T, Kubota M, Maegawa H, Udagawa J.

PLoS One. 2016 Nov 15;11(11):e0166215. doi: 10.1371/journal.pone.0166215. eCollection 2016.

16.

Enantioseparation of the carboxamide-type synthetic cannabinoids N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide and methyl [1-(5-fluoropentyl)-1H-indazole-3-carbonyl]-valinate in illicit herbal products.

Doi T, Asada A, Takeda A, Tagami T, Katagi M, Kamata H, Sawabe Y.

J Chromatogr A. 2016 Nov 18;1473:83-89. doi: 10.1016/j.chroma.2016.10.049. Epub 2016 Oct 19.

PMID:
27773389
17.

Erratum to: High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-1220, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.

Zaitsu K, Nakayama H, Yamanaka M, Hisatsune K, Taki K, Asano T, Kamata T, Katagi M, Hayashi Y, Kusano M, Tsuchihashi H, Ishii A.

Int J Legal Med. 2016 Jan;130(1):309-16. doi: 10.1007/s00414-015-1294-z. No abstract available.

PMID:
26718839
18.

Epidermis-dermis junction as a novel location for bone marrow-derived cells to reside in response to ionizing radiation.

Okano J, Kojima H, Katagi M, Nakae Y, Terashima T, Nakagawa T, Kurakane T, Okamoto N, Morohashi K, Maegawa H, Udagawa J.

Biochem Biophys Res Commun. 2015 Jun 12;461(4):695-701. doi: 10.1016/j.bbrc.2015.04.094. Epub 2015 Apr 25.

PMID:
25922286
19.

Time-course mass spectrometry imaging for depicting drug incorporation into hair.

Kamata T, Shima N, Sasaki K, Matsuta S, Takei S, Katagi M, Miki A, Zaitsu K, Nakanishi T, Sato T, Suzuki K, Tsuchihashi H.

Anal Chem. 2015 Jun 2;87(11):5476-81. doi: 10.1021/acs.analchem.5b00971. Epub 2015 May 6.

PMID:
25919888
20.

Positional isomer differentiation of synthetic cannabinoid JWH-081 by GC-MS/MS.

Kusano M, Zaitsu K, Nakayama H, Nakajima J, Hisatsune K, Moriyasu T, Matsuta S, Katagi M, Tsuchihashi H, Ishii A.

J Mass Spectrom. 2015 Mar;50(3):586-91. doi: 10.1002/jms.3565.

PMID:
25800195
21.

Metabolism of the designer drug α-pyrrolidinobutiophenone (α-PBP) in humans: identification and quantification of the phase I metabolites in urine.

Matsuta S, Shima N, Kamata H, Kakehashi H, Nakano S, Sasaki K, Kamata T, Nishioka H, Miki A, Katagi M, Zaitsu K, Sato T, Tsuchihashi H, Suzuki K.

Forensic Sci Int. 2015 Apr;249:181-8. doi: 10.1016/j.forsciint.2015.02.004. Epub 2015 Feb 8.

PMID:
25703013
22.

Hyperglycemia induces abnormal gene expression in hematopoietic stem cells and their progeny in diabetic neuropathy.

Katagi M, Terashima T, Okano J, Urabe H, Nakae Y, Ogawa N, Udagawa J, Maegawa H, Matsumura K, Chan L, Kojima H.

FEBS Lett. 2014 Mar 18;588(6):1080-6. doi: 10.1016/j.febslet.2014.02.030. Epub 2014 Feb 25.

23.

Development of a simple one-pot extraction method for various drugs and metabolites of forensic interest in blood by modifying the QuEChERS method.

Matsuta S, Nakanishi K, Miki A, Zaitsu K, Shima N, Kamata T, Nishioka H, Katagi M, Tatsuno M, Tsuboi K, Tsuchihashi H, Suzuki K.

Forensic Sci Int. 2013 Oct 10;232(1-3):40-5. doi: 10.1016/j.forsciint.2013.06.015. Epub 2013 Jul 27.

PMID:
24053863
24.

Metabolic profiling of urine and blood plasma in rat models of drug addiction on the basis of morphine, methamphetamine, and cocaine-induced conditioned place preference.

Zaitsu K, Miyawaki I, Bando K, Horie H, Shima N, Katagi M, Tatsuno M, Bamba T, Sato T, Ishii A, Tsuchihashi H, Suzuki K, Fukusaki E.

Anal Bioanal Chem. 2014 Feb;406(5):1339-54. doi: 10.1007/s00216-013-7234-1. Epub 2013 Aug 4.

PMID:
23912828
25.

Haematopoietic cells produce BDNF and regulate appetite upon migration to the hypothalamus.

Urabe H, Kojima H, Chan L, Terashima T, Ogawa N, Katagi M, Fujino K, Kumagai A, Kawai H, Asakawa A, Inui A, Yasuda H, Eguchi Y, Oka K, Maegawa H, Kashiwagi A, Kimura H.

Nat Commun. 2013;4:1526. doi: 10.1038/ncomms2536.

26.

Synthesis, spectral characterization and antimicrobial activity of substituted thiazolyl derivatives of 2-quinolones.

Katagi MS, Bolakatti GS, Badiger AM, Satyanarayana D, Mamledesai SN, Sujatha ML.

Drug Res (Stuttg). 2013 Feb;63(2):53-9. doi: 10.1055/s-0032-1331711. Epub 2013 Feb 20.

PMID:
23427049
27.

Brain-derived neurotrophic factor from bone marrow-derived cells promotes post-injury repair of peripheral nerve.

Takemura Y, Imai S, Kojima H, Katagi M, Yamakawa I, Kasahara T, Urabe H, Terashima T, Yasuda H, Chan L, Kimura H, Matsusue Y.

PLoS One. 2012;7(9):e44592. doi: 10.1371/journal.pone.0044592. Epub 2012 Sep 19.

28.

Simultaneous enantiomeric determination of MDMA and its phase I and phase II metabolites in urine by liquid chromatography-tandem mass spectrometry with chiral derivatization.

Nakanishi K, Katagi M, Zaitsu K, Shima N, Kamata H, Miki A, Kato H, Harada K, Tsuchihashi H, Suzuki K.

Anal Bioanal Chem. 2012 Nov;404(8):2427-35. doi: 10.1007/s00216-012-6385-9. Epub 2012 Sep 26.

PMID:
23010844
29.

Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement.

Nakanishi K, Miki A, Zaitsu K, Kamata H, Shima N, Kamata T, Katagi M, Tatsuno M, Tsuchihashi H, Suzuki K.

Forensic Sci Int. 2012 Apr 10;217(1-3):174-81. doi: 10.1016/j.forsciint.2011.11.003. Epub 2011 Dec 7.

PMID:
22154438
30.

Inactivation of TNF-α ameliorates diabetic neuropathy in mice.

Yamakawa I, Kojima H, Terashima T, Katagi M, Oi J, Urabe H, Sanada M, Kawai H, Chan L, Yasuda H, Maegawa H, Kimura H.

Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E844-52. doi: 10.1152/ajpendo.00029.2011. Epub 2011 Aug 2.

31.

Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat.

Shima N, Miyawaki I, Bando K, Horie H, Zaitsu K, Katagi M, Bamba T, Tsuchihashi H, Fukusaki E.

Toxicology. 2011 Sep 5;287(1-3):29-37. doi: 10.1016/j.tox.2011.05.012. Epub 2011 May 27.

PMID:
21645582
32.

MALDI-TOF and MALDI-FTICR imaging mass spectrometry of methamphetamine incorporated into hair.

Miki A, Katagi M, Kamata T, Zaitsu K, Tatsuno M, Nakanishi T, Tsuchihashi H, Takubo T, Suzuki K.

J Mass Spectrom. 2011 Apr;46(4):411-6. doi: 10.1002/jms.1908.

PMID:
21438091
33.

Homing of the bone marrow-derived interstitial cells of Cajal is decreased in diabetic mouse intestine.

Li Y, Kojima H, Fujino K, Matsumura K, Katagi M, Urabe H, Chan L, Eguchi Y, Zhao L, Kimura H.

J Gastroenterol Hepatol. 2011 Jun;26(6):1072-8. doi: 10.1111/j.1440-1746.2011.06670.x.

34.

Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture healing in diabetic mice.

Kasahara T, Imai S, Kojima H, Katagi M, Kimura H, Chan L, Matsusue Y.

Bone. 2010 Sep;47(3):617-25. doi: 10.1016/j.bone.2010.06.014. Epub 2010 Jun 19.

35.

Metabolism and toxicologic analysis of tryptamine-derived drugs of abuse.

Katagi M, Kamata T, Zaitsu K, Shima N, Kamata H, Nakanishi K, Nishioka H, Miki A, Tsuchihashi H.

Ther Drug Monit. 2010 Jun;32(3):328-31. doi: 10.1097/FTD.0b013e3181dcb40c.

PMID:
20418800
36.

Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine.

Zaitsu K, Katagi M, Kamata HT, Kamata T, Shima N, Miki A, Tsuchihashi H, Mori Y.

Forensic Sci Int. 2009 Jul 1;188(1-3):131-9. doi: 10.1016/j.forsciint.2009.04.001. Epub 2009 Apr 29.

PMID:
19406592
37.

Development of a two-step injector for GC-MS with on-column derivatization, and its application to the determination of amphetamine-type stimulants (ATS) in biological specimens.

Miki A, Katagi M, Zaitsu K, Nishioka H, Tsuchihashi H.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Apr 1;865(1-2):25-32. doi: 10.1016/j.jchromb.2008.01.051. Epub 2008 Feb 16.

PMID:
18342584
38.

Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats.

Shima N, Katagi M, Kamata H, Zaitsu K, Kamata T, Nishikawa M, Miki A, Tsuchihashi H, Sakuma T, Nemoto N.

Xenobiotica. 2008 Mar;38(3):314-24. doi: 10.1080/00498250701802506 .

PMID:
18274959
39.

Determination of a newly encountered designer drug "p-methoxyethylamphetamine" and its metabolites in human urine and blood.

Zaitsu K, Katagi M, Kamata T, Kamata H, Shima N, Tsuchihashi H, Hayashi T, Kuroki H, Matoba R.

Forensic Sci Int. 2008 May 2;177(1):77-84. Epub 2007 Dec 21.

PMID:
18155375
40.

Discrimination and identification of the six aromatic positional isomers of trimethoxyamphetamine (TMA) by gas chromatography-mass spectrometry (GC-MS).

Zaitsu K, Katagi M, Kamata H, Kamata T, Shima N, Miki A, Iwamura T, Tsuchihashi H.

J Mass Spectrom. 2008 Apr;43(4):528-34.

PMID:
18035853
41.

Oxidation of 5-methoxy-N,N-diisopropyltryptamine in rat liver microsomes and recombinant cytochrome P450 enzymes.

Narimatsu S, Yonemoto R, Masuda K, Katsu T, Asanuma M, Kamata T, Katagi M, Tsuchihashi H, Kumamoto T, Ishikawa T, Naito S, Yamano S, Hanioka N.

Biochem Pharmacol. 2008 Feb 1;75(3):752-60. Epub 2007 Sep 29.

PMID:
17980859
42.

Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.

Shima N, Kamata H, Katagi M, Tsuchihashi H, Sakuma T, Nemoto N.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 15;857(1):123-9. Epub 2007 Jul 10.

PMID:
17643356
43.
44.

Peptide YY3-36 and pancreatic polypeptide suppress food intake.

Asakawa A, Uemoto M, Ueno N, Katagi M, Fujimiya M, Fujino K, Kodama N, Nanba H, Sakamaki R, Shinfuku N, Meguid MM, Inui A.

J Gastroenterol Hepatol. 2006 Sep;21(9):1501-2. No abstract available.

PMID:
16911705
45.

Metabolism of the recently encountered designer drug, methylone, in humans and rats.

Kamata HT, Shima N, Zaitsu K, Kamata T, Miki A, Nishikawa M, Katagi M, Tsuchihashi H.

Xenobiotica. 2006 Aug;36(8):709-23.

PMID:
16891251
46.
47.

Metabolism and the urinary excretion profile of the recently scheduled designer drug N-Benzylpiperazine (BZP) in the rat.

Tsutsumi H, Katagi M, Miki A, Shima N, Kamata T, Nakajima K, Inoue H, Kishi T, Tsuchihashi H.

J Anal Toxicol. 2006 Jan-Feb;30(1):38-43.

PMID:
16620530
48.

A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy.

Tanaka E, Kamata T, Katagi M, Tsuchihashi H, Honda K.

Forensic Sci Int. 2006 Nov 10;163(1-2):152-4. Epub 2006 Jan 6.

PMID:
16406422
49.

Mosapride improves food intake, while not worsening glycemic control and obesity, in ob/ob obese mice with decreased gastric emptying.

Asakawa A, Ueno N, Katagi M, Ijuin Y, Morita Y, Mizuno S, Inui T, Sakamaki R, Shinfuku N, Uemoto M.

J Diabetes Complications. 2006 Jan-Feb;20(1):56-8.

PMID:
16389169
50.

Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.

Kamata T, Katagi M, Kamata HT, Miki A, Shima N, Zaitsu K, Nishikawa M, Tanaka E, Honda K, Tsuchihashi H.

Drug Metab Dispos. 2006 Feb;34(2):281-7. Epub 2005 Nov 9. Erratum in: Drug Metab Dispos. 2006 Mar;34(3)512.

PMID:
16280455

Supplemental Content

Loading ...
Support Center